Loading...
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct
Lopes, Renato D. Dickerson, Sheila Hafley, Gail Burns, Shana Tourt-Uhlig, Sandra White, Jennifer Newby, L. Kristin Komajda, Michel McMurray, John Bigelow, Robert
Lopes, Renato D.
Dickerson, Sheila
Hafley, Gail
Burns, Shana
Tourt-Uhlig, Sandra
White, Jennifer
Newby, L. Kristin
Komajda, Michel
McMurray, John
Bigelow, Robert
Citations
publications.citations-section.null.title:
Altmetric:
Abstract
In 2010, after regulatory review of rosiglitazone licensing, the US Food and Drug Administration ( FDA ) requested a reevaluation of cardiovascular end points in the RECORD trial.
Keywords
Date
2013
Type
Journal article
Journal
American Heart Journal
Book
Volume
166
Issue
2
Page Range
208-216
Article Number
ACU Department
Collections
Relation URI
Source URL
Event URL
Open Access Status
Open access
License
File Access
Open
Notes
© 2013, The Authors. Published by Mosby, Inc. Open access under CC BY-NC-ND license
An error occurred retrieving the object's statistics